Intracytoplasmic Sperm Injection (ICSI)

Intracytoplasmic Sperm Injection (ICSI) is an advanced assisted reproductive technique performed in conjunction with In Vitro Fertilization (IVF). While both procedures involve oocyte and spermatozoon retrieval, the primary distinction lies in the method of fertilization.

In conventional IVF, oocytes and spermatozoa are co-incubated in a specialized culture medium to achieve natural fertilization, which requires an adequate concentration of motile, morphologically normal spermatozoa. When male factor infertility or other clinical indications limit conventional fertilization, ICSI provides an established alternative.

ICSI is a micromanipulation procedure performed by experienced embryologists using specialized inverted microscopes and micro-injectors, where a single selected spermatozoon is injected directly into the cytoplasm of a mature oocyte. While ICSI overcomes sperm delivery barriers, normal embryonic cellular development remains dependent on biological processes following injection.

Indications for ICSI

From a patient perspective, the controlled ovarian stimulation and oocyte retrieval phases of an ICSI treatment cycle follow the same clinical protocol as conventional IVF. Indications include:

  • Severe oligospermia or very low spermatozoon concentration.
  • Asthenozoospermia or impaired spermatozoon motility.
  • Teratozoospermia or abnormal spermatozoon morphology.
  • Spermatozoa retrieved surgically via MESA, PESA, TESE, or TESA procedures.
  • Presence of anti-sperm antibodies in seminal fluid.
  • Previous fertilization failure in conventional IVF cycles.
Cta
Call Now